DC Field | Value | Language |
dc.contributor.author | Ungurean, Elena | - |
dc.contributor.author | Șaptefrați, Lilian | - |
dc.date.accessioned | 2023-05-10T11:32:15Z | - |
dc.date.available | 2023-05-10T11:32:15Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | UNGUREAN, Elena, ȘAPTEFRAȚI, Lilian. Biological therapies in regenerative medicine. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the national scientific conf. with internat. participation, Chișinău: CEP Medicina. 2023, p.41. ISBN 978-9975-82-313-5. | en_US |
dc.identifier.isbn | 978-9975-82-313-5 | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/24274 | - |
dc.description.abstract | Background. Regenerative medicine is a relatively new field of medicine that aims to repair or
replace damaged tissues and organs using advanced techniques such as stem cell therapy, tissue
engineering and biomaterials/scaffolds.
Objective of the study. Highlighting the main biological therapies in regenerative medicine and
their applicability.
Material and Methods. This summary is based on the analysis of international bibliographic
sources published in electronic databases such as PubMed, Frontiers and ACS.
Results. The potential therapeutic strategies of tissue engineering and regenerative medicine can be
divided in three broad categories: (1) recapitulating organ and tissue structure via scaffold
fabrication (that mimics the extracellular matrix of the target tissue), 3D bioprinting (using bioinks
mixed with living cells), and self-assembly (with special cues for guiding cells to organize
themselves into the desired tissue); (2) integrating grafts into the host via vascularization and
innervation either through the use of growth factors or by creating microchannels within the
scaffold and using co-culture models; and (3) altering the host environment to induce therapeutic
responses through cell infusion and modulating the immune system by suppressing it to prevent
rejection of a graft, engineering the responses of immune cells or changing the properties of the
implanted scaffolds. Most of these methods have successfully passed the preclinical stage of studies
and currently are in clinical testing.
Conclusions. All of these techniques have the potential to revolutionize the field of regenerative
medicine by providing replacement tissues and organs for patients with tissue damage or organ
failure. They are justly considered cost-efficient personalized strategies of treatment with quick
palpable results. However more research is needed to fully understand all the possibilities and
limitations of these techniques in order to ensure their safety and efficacy in clinical applications. | en_US |
dc.language.iso | en | en_US |
dc.publisher | CEP Medicina | en_US |
dc.relation.ispartof | „Cells and tissues transplantation. Actualities and perspectives” dedicated to the 10th anniversary of the founding of the Human Tissue and Cells Bank and to the 15th anniversary of the founding of the Laboratory of Tissue Engineering and Cells Culture of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, March 17-18th 2023, Chisinau, Republic of Moldova | en_US |
dc.subject | regenerative medicine | en_US |
dc.subject | tissue engineering | en_US |
dc.subject | scaffold | en_US |
dc.subject | 3D bioprinting | en_US |
dc.subject | growth factors | en_US |
dc.title | Biological therapies in regenerative medicine | en_US |
dc.type | Other | en_US |
Appears in Collections: | The Materials of the National Scientific Conference with International Participation „Cells and tissues transplantation. Actualities and perspectives”
|